Core Research

Since the founding of Genodix in '96, our scientists have developed a well-diversified research and development program. Their years of hard work and effort have led to significant and broad scientific advances, producing a pipeline of remarkable and innovative pharmaceutical products.

Immune Disorders

Genodix has a solid research core in immunology. By studying the interaction between tumor viruses and the genetic material of the cell and taking advantage of the organizer effect in embryonic development, we have made substantial discoveries concerning the specificity of the cell mediated immune defenses. Leveraging this information will allow us to design synthetic compounds that inhibit the action of certain body substances, especially actions on the vascular system and the skeletal muscles. Genodix currently has three such compounds in various stages of clinical trials.

Obesity

Genodix scientists are world experts in the nature and mode of action of oxidation enzymes, and the course of the catalytic conversion of glycogen. Their work on protein engineering is paving the way for Genodix to become market leaders in the pharmaceutical treatment of obesity.

Anitbodies

Genodix is also pushing the forefront of genetic immunology. By producing mutations by means of X-ray irradiation, our scientists have developed novel methods of engineering the chemical structure of antibodies. Genodix-manufactured enzymes have a higher binding specificity and shorter production time than those produced by conventional methods.

Neurobiology

The sequencing of the human genome has allowed Genodix scientists to study mobile genetic elements, and to determine their effects on the highly differentiated functions of single nerve fibers. Such fundamental work on neurological function is a long-term strategy at Genodix. Our vision is to discover the core engineering principles of neurobioloy which will eventually lead to the repair of nerve damage and a better understanding of human consciousness--breakthroughs as capable of fundamental changes in health care as the discovery of penicillin.